Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background & aimsEpidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study to determine the associations between circulating concentrations of 25(OH)D and risks of EAC and its precursor, Barrett's esophagus (BE).MethodsWe conducted a Mendelian randomization study using a 2-sample (summary data) approach. Six single-nucleotide polymorphisms (SNPs; rs3755967, rs10741657, rs12785878, rs10745742, rs8018720, and rs17216707) associated with circulating concentrations of 25(OH)D were used as instrumental variables. We collected data from 6167 patients with BE, 4112 patients with EAC, and 17,159 individuals without BE or EAC (controls) participating in the Barrett's and Esophageal Adenocarcinoma Consortium, as well as studies from Bonn, Germany, and Cambridge and Oxford, United Kingdom. Analyses were performed separately for BE and EAC.ResultsOverall, we found no evidence for an association between genetically estimated 25(OH)D concentration and risk of BE or EAC. The odds ratio per 20 nmol/L increase in genetically estimated 25(OH)D concentration for BE risk estimated by combining the individual SNP association using inverse variance weighting was 1.21 (95% CI, 0.77-1.92; P = .41). The odds ratio for EAC risk, estimated by combining the individual SNP association using inverse variance weighting, was 0.68 (95% CI, 0.39-1.19; P = .18).ConclusionsIn a Mendelian randomization study, we found that low genetically estimated 25(OH)D concentrations were not associated with risk of BE or EAC.

Original publication

DOI

10.1016/j.cgh.2019.01.041

Type

Journal article

Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Publication Date

10/2019

Volume

17

Pages

2227 - 2235.e1

Addresses

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.

Keywords

Stomach and Esophageal Cancer Study Consortium, Humans, Adenocarcinoma, Esophageal Neoplasms, Barrett Esophagus, Vitamin D, DNA, Neoplasm, Morbidity, Risk Assessment, Risk Factors, Polymorphism, Single Nucleotide, North America, Europe, Female, Male, Mendelian Randomization Analysis, Biomarkers, Tumor